nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CYP3A7—Dapsone—systemic lupus erythematosus	0.0361	0.0705	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0361	0.0705	CbGbCtD
Aripiprazole—CYP3A5—Dapsone—systemic lupus erythematosus	0.0271	0.0529	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0251	0.049	CbGbCtD
Aripiprazole—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0251	0.049	CbGbCtD
Aripiprazole—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0237	0.0463	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0237	0.0463	CbGbCtD
Aripiprazole—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0235	0.0458	CbGbCtD
Aripiprazole—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0202	0.0394	CbGbCtD
Aripiprazole—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0189	0.0368	CbGbCtD
Aripiprazole—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0178	0.0347	CbGbCtD
Aripiprazole—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.0156	0.0305	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.0156	0.0305	CbGbCtD
Aripiprazole—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0153	0.0298	CbGbCtD
Aripiprazole—ABCB1—Betamethasone—systemic lupus erythematosus	0.0131	0.0256	CbGbCtD
Aripiprazole—ABCB1—Prednisolone—systemic lupus erythematosus	0.0129	0.0253	CbGbCtD
Aripiprazole—HTR2B—cardial valve—systemic lupus erythematosus	0.0126	0.12	CbGeAlD
Aripiprazole—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0123	0.0239	CbGbCtD
Aripiprazole—ABCB1—Prednisone—systemic lupus erythematosus	0.0122	0.0239	CbGbCtD
Aripiprazole—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0121	0.0236	CbGbCtD
Aripiprazole—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0117	0.0229	CbGbCtD
Aripiprazole—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0116	0.0226	CbGbCtD
Aripiprazole—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0109	0.0213	CbGbCtD
Aripiprazole—HTR2C—choroid plexus—systemic lupus erythematosus	0.0108	0.103	CbGeAlD
Aripiprazole—CYP3A4—Dapsone—systemic lupus erythematosus	0.0106	0.0206	CbGbCtD
Aripiprazole—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00916	0.0179	CbGbCtD
Aripiprazole—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00916	0.0179	CbGbCtD
Aripiprazole—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00786	0.0153	CbGbCtD
Aripiprazole—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00775	0.0151	CbGbCtD
Aripiprazole—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00763	0.0149	CbGbCtD
Aripiprazole—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00735	0.0143	CbGbCtD
Aripiprazole—CYP3A4—Prednisone—systemic lupus erythematosus	0.00732	0.0143	CbGbCtD
Aripiprazole—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00719	0.014	CbGbCtD
Aripiprazole—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00694	0.0135	CbGbCtD
Aripiprazole—ABCB1—Methotrexate—systemic lupus erythematosus	0.00613	0.012	CbGbCtD
Aripiprazole—HTR2A—choroid plexus—systemic lupus erythematosus	0.00543	0.0517	CbGeAlD
Aripiprazole—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00457	0.00892	CbGbCtD
Aripiprazole—HTR2A—urine—systemic lupus erythematosus	0.00145	0.0138	CbGeAlD
Aripiprazole—SLC6A4—blood plasma—systemic lupus erythematosus	0.00143	0.0136	CbGeAlD
Aripiprazole—HTR7—endothelium—systemic lupus erythematosus	0.00137	0.013	CbGeAlD
Aripiprazole—CYP3A4—urine—systemic lupus erythematosus	0.00135	0.0128	CbGeAlD
Aripiprazole—CYP2D6—urine—systemic lupus erythematosus	0.00132	0.0126	CbGeAlD
Aripiprazole—HTR1A—blood plasma—systemic lupus erythematosus	0.00127	0.0121	CbGeAlD
Aripiprazole—HTR7—blood plasma—systemic lupus erythematosus	0.00122	0.0116	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.00117	0.0111	CbGeAlD
Aripiprazole—CHRM5—skin of body—systemic lupus erythematosus	0.0011	0.0104	CbGeAlD
Aripiprazole—H1F0—connective tissue—systemic lupus erythematosus	0.00105	0.00998	CbGeAlD
Aripiprazole—H1F0—nephron tubule—systemic lupus erythematosus	0.00102	0.00967	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.000998	0.00949	CbGeAlD
Aripiprazole—DRD5—lymphoid tissue—systemic lupus erythematosus	0.000992	0.00943	CbGeAlD
Aripiprazole—HTR1E—nervous system—systemic lupus erythematosus	0.000992	0.00943	CbGeAlD
Aripiprazole—HTR1E—central nervous system—systemic lupus erythematosus	0.000955	0.00908	CbGeAlD
Aripiprazole—H1F0—skin of body—systemic lupus erythematosus	0.000948	0.00901	CbGeAlD
Aripiprazole—ADRA1B—kidney—systemic lupus erythematosus	0.000947	0.009	CbGeAlD
Aripiprazole—CYP3A5—blood plasma—systemic lupus erythematosus	0.000936	0.0089	CbGeAlD
Aripiprazole—H1F0—kidney—systemic lupus erythematosus	0.000894	0.0085	CbGeAlD
Aripiprazole—ADRA2A—blood plasma—systemic lupus erythematosus	0.000893	0.00848	CbGeAlD
Aripiprazole—H1F0—cortex of kidney—systemic lupus erythematosus	0.000871	0.00827	CbGeAlD
Aripiprazole—CHRM4—nervous system—systemic lupus erythematosus	0.00087	0.00827	CbGeAlD
Aripiprazole—HTR2A—endothelium—systemic lupus erythematosus	0.000855	0.00812	CbGeAlD
Aripiprazole—CHRM4—central nervous system—systemic lupus erythematosus	0.000838	0.00796	CbGeAlD
Aripiprazole—HTR1D—connective tissue—systemic lupus erythematosus	0.000813	0.00773	CbGeAlD
Aripiprazole—DRD3—nervous system—systemic lupus erythematosus	0.000809	0.00769	CbGeAlD
Aripiprazole—ADRB1—connective tissue—systemic lupus erythematosus	0.00079	0.00751	CbGeAlD
Aripiprazole—DRD3—central nervous system—systemic lupus erythematosus	0.000779	0.0074	CbGeAlD
Aripiprazole—HTR6—nervous system—systemic lupus erythematosus	0.000779	0.0074	CbGeAlD
Aripiprazole—H1F0—lymphoid tissue—systemic lupus erythematosus	0.000768	0.0073	CbGeAlD
Aripiprazole—HTR2A—blood plasma—systemic lupus erythematosus	0.000759	0.00721	CbGeAlD
Aripiprazole—DRD5—nervous system—systemic lupus erythematosus	0.000758	0.0072	CbGeAlD
Aripiprazole—HTR6—central nervous system—systemic lupus erythematosus	0.00075	0.00712	CbGeAlD
Aripiprazole—DRD5—central nervous system—systemic lupus erythematosus	0.00073	0.00694	CbGeAlD
Aripiprazole—H1F0—tendon—systemic lupus erythematosus	0.000722	0.00686	CbGeAlD
Aripiprazole—CYP3A4—blood plasma—systemic lupus erythematosus	0.000703	0.00668	CbGeAlD
Aripiprazole—H1F0—bone marrow—systemic lupus erythematosus	0.000699	0.00664	CbGeAlD
Aripiprazole—HTR1D—kidney—systemic lupus erythematosus	0.000692	0.00658	CbGeAlD
Aripiprazole—CYP2D6—blood plasma—systemic lupus erythematosus	0.000691	0.00657	CbGeAlD
Aripiprazole—HTR2B—skin of body—systemic lupus erythematosus	0.000683	0.00649	CbGeAlD
Aripiprazole—CHRM5—nervous system—systemic lupus erythematosus	0.00068	0.00646	CbGeAlD
Aripiprazole—CHRM5—central nervous system—systemic lupus erythematosus	0.000655	0.00622	CbGeAlD
Aripiprazole—HTR7—connective tissue—systemic lupus erythematosus	0.000648	0.00616	CbGeAlD
Aripiprazole—H1F0—lung—systemic lupus erythematosus	0.000633	0.00602	CbGeAlD
Aripiprazole—HTR2B—cortex of kidney—systemic lupus erythematosus	0.000627	0.00596	CbGeAlD
Aripiprazole—ADRA1B—nervous system—systemic lupus erythematosus	0.000621	0.00591	CbGeAlD
Aripiprazole—HTR3A—lung—systemic lupus erythematosus	0.000604	0.00574	CbGeAlD
Aripiprazole—ADRA1B—central nervous system—systemic lupus erythematosus	0.000598	0.00569	CbGeAlD
Aripiprazole—H1F0—nervous system—systemic lupus erythematosus	0.000587	0.00557	CbGeAlD
Aripiprazole—CHRM3—kidney—systemic lupus erythematosus	0.00058	0.00551	CbGeAlD
Aripiprazole—DRD1—nervous system—systemic lupus erythematosus	0.000579	0.0055	CbGeAlD
Aripiprazole—ADRA2C—nephron tubule—systemic lupus erythematosus	0.000577	0.00548	CbGeAlD
Aripiprazole—H1F0—central nervous system—systemic lupus erythematosus	0.000565	0.00537	CbGeAlD
Aripiprazole—HTR3A—nervous system—systemic lupus erythematosus	0.000559	0.00532	CbGeAlD
Aripiprazole—DRD1—central nervous system—systemic lupus erythematosus	0.000558	0.0053	CbGeAlD
Aripiprazole—HTR7—kidney—systemic lupus erythematosus	0.000552	0.00524	CbGeAlD
Aripiprazole—HTR3A—central nervous system—systemic lupus erythematosus	0.000539	0.00512	CbGeAlD
Aripiprazole—HTR2B—tendon—systemic lupus erythematosus	0.00052	0.00494	CbGeAlD
Aripiprazole—ADRA2C—kidney—systemic lupus erythematosus	0.000507	0.00482	CbGeAlD
Aripiprazole—ABCB1—blood plasma—systemic lupus erythematosus	0.000497	0.00473	CbGeAlD
Aripiprazole—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.000494	0.00469	CbGeAlD
Aripiprazole—HRH1—connective tissue—systemic lupus erythematosus	0.000484	0.0046	CbGeAlD
Aripiprazole—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000483	0.00459	CbGeAlD
Aripiprazole—ADRB1—lung—systemic lupus erythematosus	0.000477	0.00453	CbGeAlD
Aripiprazole—ADRA2A—connective tissue—systemic lupus erythematosus	0.000475	0.00452	CbGeAlD
Aripiprazole—HTR1B—nervous system—systemic lupus erythematosus	0.000469	0.00446	CbGeAlD
Aripiprazole—CHRM2—nervous system—systemic lupus erythematosus	0.000467	0.00444	CbGeAlD
Aripiprazole—SLC6A4—lung—systemic lupus erythematosus	0.000461	0.00438	CbGeAlD
Aripiprazole—CHRM1—lung—systemic lupus erythematosus	0.000459	0.00436	CbGeAlD
Aripiprazole—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.000457	0.00434	CbGeAlD
Aripiprazole—HTR2B—lung—systemic lupus erythematosus	0.000456	0.00434	CbGeAlD
Aripiprazole—HTR1D—nervous system—systemic lupus erythematosus	0.000454	0.00432	CbGeAlD
Aripiprazole—HTR1B—central nervous system—systemic lupus erythematosus	0.000452	0.00429	CbGeAlD
Aripiprazole—HTR2C—nervous system—systemic lupus erythematosus	0.00045	0.00428	CbGeAlD
Aripiprazole—CHRM2—central nervous system—systemic lupus erythematosus	0.000449	0.00427	CbGeAlD
Aripiprazole—HTR7—tendon—systemic lupus erythematosus	0.000445	0.00423	CbGeAlD
Aripiprazole—ADRB1—nervous system—systemic lupus erythematosus	0.000442	0.0042	CbGeAlD
Aripiprazole—HTR1D—central nervous system—systemic lupus erythematosus	0.000437	0.00416	CbGeAlD
Aripiprazole—HTR2C—central nervous system—systemic lupus erythematosus	0.000433	0.00412	CbGeAlD
Aripiprazole—SLC6A4—nervous system—systemic lupus erythematosus	0.000427	0.00405	CbGeAlD
Aripiprazole—ADRB1—central nervous system—systemic lupus erythematosus	0.000425	0.00404	CbGeAlD
Aripiprazole—CHRM1—nervous system—systemic lupus erythematosus	0.000425	0.00404	CbGeAlD
Aripiprazole—CYP3A5—kidney—systemic lupus erythematosus	0.000424	0.00403	CbGeAlD
Aripiprazole—HTR2B—nervous system—systemic lupus erythematosus	0.000423	0.00402	CbGeAlD
Aripiprazole—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000413	0.00393	CbGeAlD
Aripiprazole—SLC6A4—central nervous system—systemic lupus erythematosus	0.000411	0.0039	CbGeAlD
Aripiprazole—ADRA2C—tendon—systemic lupus erythematosus	0.000409	0.00389	CbGeAlD
Aripiprazole—CHRM1—central nervous system—systemic lupus erythematosus	0.000409	0.00389	CbGeAlD
Aripiprazole—HTR2B—central nervous system—systemic lupus erythematosus	0.000407	0.00387	CbGeAlD
Aripiprazole—HTR2A—connective tissue—systemic lupus erythematosus	0.000404	0.00384	CbGeAlD
Aripiprazole—KCNH2—bone marrow—systemic lupus erythematosus	0.000402	0.00382	CbGeAlD
Aripiprazole—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000394	0.00374	CbGeAlD
Aripiprazole—HTR7—lung—systemic lupus erythematosus	0.000391	0.00371	CbGeAlD
Aripiprazole—CHRM3—nervous system—systemic lupus erythematosus	0.00038	0.00361	CbGeAlD
Aripiprazole—HTR1A—nervous system—systemic lupus erythematosus	0.000379	0.0036	CbGeAlD
Aripiprazole—DRD2—lung—systemic lupus erythematosus	0.00037	0.00351	CbGeAlD
Aripiprazole—CHRM3—central nervous system—systemic lupus erythematosus	0.000366	0.00348	CbGeAlD
Aripiprazole—HTR1A—central nervous system—systemic lupus erythematosus	0.000365	0.00347	CbGeAlD
Aripiprazole—HTR7—nervous system—systemic lupus erythematosus	0.000362	0.00344	CbGeAlD
Aripiprazole—ADRA2C—lung—systemic lupus erythematosus	0.000359	0.00341	CbGeAlD
Aripiprazole—ADRA1A—nervous system—systemic lupus erythematosus	0.000349	0.00332	CbGeAlD
Aripiprazole—HTR7—central nervous system—systemic lupus erythematosus	0.000348	0.00331	CbGeAlD
Aripiprazole—HTR2A—kidney—systemic lupus erythematosus	0.000344	0.00327	CbGeAlD
Aripiprazole—DRD2—nervous system—systemic lupus erythematosus	0.000342	0.00325	CbGeAlD
Aripiprazole—KCNH2—nervous system—systemic lupus erythematosus	0.000337	0.0032	CbGeAlD
Aripiprazole—ADRA1A—central nervous system—systemic lupus erythematosus	0.000336	0.00319	CbGeAlD
Aripiprazole—ADRA2C—nervous system—systemic lupus erythematosus	0.000333	0.00316	CbGeAlD
Aripiprazole—HRH1—tendon—systemic lupus erythematosus	0.000333	0.00316	CbGeAlD
Aripiprazole—DRD2—central nervous system—systemic lupus erythematosus	0.000329	0.00313	CbGeAlD
Aripiprazole—ADRA2A—tendon—systemic lupus erythematosus	0.000327	0.0031	CbGeAlD
Aripiprazole—KCNH2—central nervous system—systemic lupus erythematosus	0.000325	0.00309	CbGeAlD
Aripiprazole—ADRA2C—central nervous system—systemic lupus erythematosus	0.00032	0.00304	CbGeAlD
Aripiprazole—CYP3A4—kidney—systemic lupus erythematosus	0.000318	0.00303	CbGeAlD
Aripiprazole—CYP2D6—kidney—systemic lupus erythematosus	0.000313	0.00298	CbGeAlD
Aripiprazole—CYP3A5—lung—systemic lupus erythematosus	0.000301	0.00286	CbGeAlD
Aripiprazole—HRH1—lung—systemic lupus erythematosus	0.000292	0.00277	CbGeAlD
Aripiprazole—ADRA2A—lung—systemic lupus erythematosus	0.000287	0.00272	CbGeAlD
Aripiprazole—HTR2A—tendon—systemic lupus erythematosus	0.000278	0.00264	CbGeAlD
Aripiprazole—HRH1—nervous system—systemic lupus erythematosus	0.00027	0.00257	CbGeAlD
Aripiprazole—ADRA2A—nervous system—systemic lupus erythematosus	0.000265	0.00252	CbGeAlD
Aripiprazole—HRH1—central nervous system—systemic lupus erythematosus	0.00026	0.00247	CbGeAlD
Aripiprazole—ABCB1—nephron tubule—systemic lupus erythematosus	0.000257	0.00244	CbGeAlD
Aripiprazole—ADRA2A—central nervous system—systemic lupus erythematosus	0.000256	0.00243	CbGeAlD
Aripiprazole—HTR2A—lung—systemic lupus erythematosus	0.000244	0.00232	CbGeAlD
Aripiprazole—HTR2A—nervous system—systemic lupus erythematosus	0.000226	0.00215	CbGeAlD
Aripiprazole—ABCB1—kidney—systemic lupus erythematosus	0.000225	0.00214	CbGeAlD
Aripiprazole—ABCB1—cortex of kidney—systemic lupus erythematosus	0.00022	0.00209	CbGeAlD
Aripiprazole—HTR2A—central nervous system—systemic lupus erythematosus	0.000217	0.00207	CbGeAlD
Aripiprazole—CYP3A4—nervous system—systemic lupus erythematosus	0.000209	0.00199	CbGeAlD
Aripiprazole—CYP2D6—nervous system—systemic lupus erythematosus	0.000206	0.00195	CbGeAlD
Aripiprazole—CYP3A4—central nervous system—systemic lupus erythematosus	0.000201	0.00191	CbGeAlD
Aripiprazole—CYP2D6—central nervous system—systemic lupus erythematosus	0.000198	0.00188	CbGeAlD
Aripiprazole—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000194	0.00184	CbGeAlD
Aripiprazole—ABCB1—bone marrow—systemic lupus erythematosus	0.000176	0.00168	CbGeAlD
Aripiprazole—ABCB1—lung—systemic lupus erythematosus	0.00016	0.00152	CbGeAlD
Aripiprazole—ABCB1—nervous system—systemic lupus erythematosus	0.000148	0.00141	CbGeAlD
Aripiprazole—ABCB1—central nervous system—systemic lupus erythematosus	0.000142	0.00135	CbGeAlD
Aripiprazole—Oedema—Betamethasone—systemic lupus erythematosus	5.96e-05	0.000188	CcSEcCtD
Aripiprazole—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	5.96e-05	0.000188	CcSEcCtD
Aripiprazole—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	5.96e-05	0.000188	CcSEcCtD
Aripiprazole—Oedema—Dexamethasone—systemic lupus erythematosus	5.96e-05	0.000188	CcSEcCtD
Aripiprazole—Insomnia—Triamcinolone—systemic lupus erythematosus	5.95e-05	0.000187	CcSEcCtD
Aripiprazole—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.93e-05	0.000187	CcSEcCtD
Aripiprazole—Infection—Dexamethasone—systemic lupus erythematosus	5.93e-05	0.000187	CcSEcCtD
Aripiprazole—Infection—Betamethasone—systemic lupus erythematosus	5.93e-05	0.000187	CcSEcCtD
Aripiprazole—Ill-defined disorder—Prednisone—systemic lupus erythematosus	5.91e-05	0.000186	CcSEcCtD
Aripiprazole—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.9e-05	0.000186	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisolone—systemic lupus erythematosus	5.89e-05	0.000186	CcSEcCtD
Aripiprazole—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.89e-05	0.000185	CcSEcCtD
Aripiprazole—Visual impairment—Methotrexate—systemic lupus erythematosus	5.89e-05	0.000185	CcSEcCtD
Aripiprazole—Anaemia—Prednisone—systemic lupus erythematosus	5.88e-05	0.000185	CcSEcCtD
Aripiprazole—Shock—Dexamethasone—systemic lupus erythematosus	5.87e-05	0.000185	CcSEcCtD
Aripiprazole—Shock—Betamethasone—systemic lupus erythematosus	5.87e-05	0.000185	CcSEcCtD
Aripiprazole—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.86e-05	0.000185	CcSEcCtD
Aripiprazole—Nervous system disorder—Betamethasone—systemic lupus erythematosus	5.85e-05	0.000184	CcSEcCtD
Aripiprazole—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	5.85e-05	0.000184	CcSEcCtD
Aripiprazole—Agitation—Prednisone—systemic lupus erythematosus	5.85e-05	0.000184	CcSEcCtD
Aripiprazole—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.84e-05	0.000184	CcSEcCtD
Aripiprazole—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.84e-05	0.000184	CcSEcCtD
Aripiprazole—Tachycardia—Betamethasone—systemic lupus erythematosus	5.82e-05	0.000183	CcSEcCtD
Aripiprazole—Tachycardia—Dexamethasone—systemic lupus erythematosus	5.82e-05	0.000183	CcSEcCtD
Aripiprazole—Angioedema—Prednisone—systemic lupus erythematosus	5.82e-05	0.000183	CcSEcCtD
Aripiprazole—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	5.79e-05	0.000182	CcSEcCtD
Aripiprazole—Dyspepsia—Triamcinolone—systemic lupus erythematosus	5.79e-05	0.000182	CcSEcCtD
Aripiprazole—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	5.77e-05	0.000182	CcSEcCtD
Aripiprazole—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	5.77e-05	0.000182	CcSEcCtD
Aripiprazole—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	5.77e-05	0.000182	CcSEcCtD
Aripiprazole—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	5.75e-05	0.000181	CcSEcCtD
Aripiprazole—Malaise—Prednisone—systemic lupus erythematosus	5.74e-05	0.000181	CcSEcCtD
Aripiprazole—Vertigo—Prednisone—systemic lupus erythematosus	5.72e-05	0.00018	CcSEcCtD
Aripiprazole—Eye disorder—Methotrexate—systemic lupus erythematosus	5.71e-05	0.00018	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.71e-05	0.00018	CcSEcCtD
Aripiprazole—Syncope—Prednisone—systemic lupus erythematosus	5.71e-05	0.00018	CcSEcCtD
Aripiprazole—Tinnitus—Methotrexate—systemic lupus erythematosus	5.7e-05	0.000179	CcSEcCtD
Aripiprazole—Anorexia—Dexamethasone—systemic lupus erythematosus	5.69e-05	0.000179	CcSEcCtD
Aripiprazole—Anorexia—Betamethasone—systemic lupus erythematosus	5.69e-05	0.000179	CcSEcCtD
Aripiprazole—Urticaria—Prednisolone—systemic lupus erythematosus	5.68e-05	0.000179	CcSEcCtD
Aripiprazole—Cardiac disorder—Methotrexate—systemic lupus erythematosus	5.67e-05	0.000179	CcSEcCtD
Aripiprazole—Fatigue—Triamcinolone—systemic lupus erythematosus	5.67e-05	0.000178	CcSEcCtD
Aripiprazole—Fatigue—Methylprednisolone—systemic lupus erythematosus	5.66e-05	0.000178	CcSEcCtD
Aripiprazole—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	5.65e-05	0.000178	CcSEcCtD
Aripiprazole—Asthenia—Cyclosporine—systemic lupus erythematosus	5.64e-05	0.000177	CcSEcCtD
Aripiprazole—Pain—Triamcinolone—systemic lupus erythematosus	5.62e-05	0.000177	CcSEcCtD
Aripiprazole—Loss of consciousness—Prednisone—systemic lupus erythematosus	5.59e-05	0.000176	CcSEcCtD
Aripiprazole—Hypotension—Betamethasone—systemic lupus erythematosus	5.57e-05	0.000176	CcSEcCtD
Aripiprazole—Hypotension—Dexamethasone—systemic lupus erythematosus	5.57e-05	0.000176	CcSEcCtD
Aripiprazole—Pruritus—Cyclosporine—systemic lupus erythematosus	5.56e-05	0.000175	CcSEcCtD
Aripiprazole—Urticaria—Hydrocortisone—systemic lupus erythematosus	5.55e-05	0.000175	CcSEcCtD
Aripiprazole—Angiopathy—Methotrexate—systemic lupus erythematosus	5.54e-05	0.000175	CcSEcCtD
Aripiprazole—Immune system disorder—Methotrexate—systemic lupus erythematosus	5.52e-05	0.000174	CcSEcCtD
Aripiprazole—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.52e-05	0.000174	CcSEcCtD
Aripiprazole—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.52e-05	0.000174	CcSEcCtD
Aripiprazole—Convulsion—Prednisone—systemic lupus erythematosus	5.51e-05	0.000174	CcSEcCtD
Aripiprazole—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	5.51e-05	0.000173	CcSEcCtD
Aripiprazole—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.5e-05	0.000173	CcSEcCtD
Aripiprazole—Hypertension—Prednisone—systemic lupus erythematosus	5.5e-05	0.000173	CcSEcCtD
Aripiprazole—Chills—Methotrexate—systemic lupus erythematosus	5.48e-05	0.000173	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	5.43e-05	0.000171	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	5.43e-05	0.000171	CcSEcCtD
Aripiprazole—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.42e-05	0.000171	CcSEcCtD
Aripiprazole—Arthralgia—Prednisone—systemic lupus erythematosus	5.42e-05	0.000171	CcSEcCtD
Aripiprazole—Myalgia—Prednisone—systemic lupus erythematosus	5.42e-05	0.000171	CcSEcCtD
Aripiprazole—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	5.42e-05	0.000171	CcSEcCtD
Aripiprazole—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	5.41e-05	0.00017	CcSEcCtD
Aripiprazole—Anxiety—Prednisone—systemic lupus erythematosus	5.4e-05	0.00017	CcSEcCtD
Aripiprazole—Alopecia—Methotrexate—systemic lupus erythematosus	5.4e-05	0.00017	CcSEcCtD
Aripiprazole—Insomnia—Betamethasone—systemic lupus erythematosus	5.39e-05	0.00017	CcSEcCtD
Aripiprazole—Insomnia—Dexamethasone—systemic lupus erythematosus	5.39e-05	0.00017	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	5.38e-05	0.000169	CcSEcCtD
Aripiprazole—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.37e-05	0.000169	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.36e-05	0.000169	CcSEcCtD
Aripiprazole—Paraesthesia—Betamethasone—systemic lupus erythematosus	5.36e-05	0.000169	CcSEcCtD
Aripiprazole—Paraesthesia—Dexamethasone—systemic lupus erythematosus	5.36e-05	0.000169	CcSEcCtD
Aripiprazole—Discomfort—Prednisone—systemic lupus erythematosus	5.35e-05	0.000169	CcSEcCtD
Aripiprazole—Mental disorder—Methotrexate—systemic lupus erythematosus	5.35e-05	0.000169	CcSEcCtD
Aripiprazole—Malnutrition—Methotrexate—systemic lupus erythematosus	5.32e-05	0.000168	CcSEcCtD
Aripiprazole—Erythema—Methotrexate—systemic lupus erythematosus	5.32e-05	0.000168	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisolone—systemic lupus erythematosus	5.27e-05	0.000166	CcSEcCtD
Aripiprazole—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.25e-05	0.000165	CcSEcCtD
Aripiprazole—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.25e-05	0.000165	CcSEcCtD
Aripiprazole—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.24e-05	0.000165	CcSEcCtD
Aripiprazole—Urticaria—Triamcinolone—systemic lupus erythematosus	5.22e-05	0.000164	CcSEcCtD
Aripiprazole—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.21e-05	0.000164	CcSEcCtD
Aripiprazole—Dysgeusia—Methotrexate—systemic lupus erythematosus	5.21e-05	0.000164	CcSEcCtD
Aripiprazole—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.2e-05	0.000164	CcSEcCtD
Aripiprazole—Dizziness—Cyclosporine—systemic lupus erythematosus	5.19e-05	0.000164	CcSEcCtD
Aripiprazole—Oedema—Prednisone—systemic lupus erythematosus	5.19e-05	0.000164	CcSEcCtD
Aripiprazole—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.19e-05	0.000164	CcSEcCtD
Aripiprazole—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.19e-05	0.000163	CcSEcCtD
Aripiprazole—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.19e-05	0.000163	CcSEcCtD
Aripiprazole—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.19e-05	0.000163	CcSEcCtD
Aripiprazole—Infection—Prednisone—systemic lupus erythematosus	5.16e-05	0.000163	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	5.15e-05	0.000162	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	5.15e-05	0.000162	CcSEcCtD
Aripiprazole—Back pain—Methotrexate—systemic lupus erythematosus	5.15e-05	0.000162	CcSEcCtD
Aripiprazole—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	5.14e-05	0.000162	CcSEcCtD
Aripiprazole—Fatigue—Dexamethasone—systemic lupus erythematosus	5.14e-05	0.000162	CcSEcCtD
Aripiprazole—Fatigue—Betamethasone—systemic lupus erythematosus	5.14e-05	0.000162	CcSEcCtD
Aripiprazole—Shock—Prednisone—systemic lupus erythematosus	5.11e-05	0.000161	CcSEcCtD
Aripiprazole—Pain—Dexamethasone—systemic lupus erythematosus	5.1e-05	0.000161	CcSEcCtD
Aripiprazole—Pain—Betamethasone—systemic lupus erythematosus	5.1e-05	0.000161	CcSEcCtD
Aripiprazole—Nervous system disorder—Prednisone—systemic lupus erythematosus	5.09e-05	0.00016	CcSEcCtD
Aripiprazole—Tachycardia—Prednisone—systemic lupus erythematosus	5.07e-05	0.00016	CcSEcCtD
Aripiprazole—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.07e-05	0.00016	CcSEcCtD
Aripiprazole—Skin disorder—Prednisone—systemic lupus erythematosus	5.05e-05	0.000159	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisone—systemic lupus erythematosus	5.02e-05	0.000158	CcSEcCtD
Aripiprazole—Vision blurred—Methotrexate—systemic lupus erythematosus	5.01e-05	0.000158	CcSEcCtD
Aripiprazole—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.01e-05	0.000158	CcSEcCtD
Aripiprazole—Vomiting—Cyclosporine—systemic lupus erythematosus	4.99e-05	0.000157	CcSEcCtD
Aripiprazole—Rash—Cyclosporine—systemic lupus erythematosus	4.95e-05	0.000156	CcSEcCtD
Aripiprazole—Anorexia—Prednisone—systemic lupus erythematosus	4.95e-05	0.000156	CcSEcCtD
Aripiprazole—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.95e-05	0.000156	CcSEcCtD
Aripiprazole—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.94e-05	0.000156	CcSEcCtD
Aripiprazole—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4.94e-05	0.000155	CcSEcCtD
Aripiprazole—Headache—Cyclosporine—systemic lupus erythematosus	4.92e-05	0.000155	CcSEcCtD
Aripiprazole—Anaemia—Methotrexate—systemic lupus erythematosus	4.92e-05	0.000155	CcSEcCtD
Aripiprazole—Feeling abnormal—Betamethasone—systemic lupus erythematosus	4.92e-05	0.000155	CcSEcCtD
Aripiprazole—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	4.92e-05	0.000155	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.88e-05	0.000154	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.88e-05	0.000154	CcSEcCtD
Aripiprazole—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.87e-05	0.000153	CcSEcCtD
Aripiprazole—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	4.84e-05	0.000153	CcSEcCtD
Aripiprazole—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	4.83e-05	0.000152	CcSEcCtD
Aripiprazole—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.83e-05	0.000152	CcSEcCtD
Aripiprazole—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.83e-05	0.000152	CcSEcCtD
Aripiprazole—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.8e-05	0.000151	CcSEcCtD
Aripiprazole—Malaise—Methotrexate—systemic lupus erythematosus	4.8e-05	0.000151	CcSEcCtD
Aripiprazole—Vertigo—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000151	CcSEcCtD
Aripiprazole—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.78e-05	0.00015	CcSEcCtD
Aripiprazole—Leukopenia—Methotrexate—systemic lupus erythematosus	4.76e-05	0.00015	CcSEcCtD
Aripiprazole—Urticaria—Betamethasone—systemic lupus erythematosus	4.74e-05	0.000149	CcSEcCtD
Aripiprazole—Urticaria—Dexamethasone—systemic lupus erythematosus	4.74e-05	0.000149	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.73e-05	0.000149	CcSEcCtD
Aripiprazole—Dizziness—Prednisolone—systemic lupus erythematosus	4.73e-05	0.000149	CcSEcCtD
Aripiprazole—Asthenia—Triamcinolone—systemic lupus erythematosus	4.72e-05	0.000149	CcSEcCtD
Aripiprazole—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000148	CcSEcCtD
Aripiprazole—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000148	CcSEcCtD
Aripiprazole—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000148	CcSEcCtD
Aripiprazole—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000148	CcSEcCtD
Aripiprazole—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.71e-05	0.000148	CcSEcCtD
Aripiprazole—Insomnia—Prednisone—systemic lupus erythematosus	4.7e-05	0.000148	CcSEcCtD
Aripiprazole—Nausea—Cyclosporine—systemic lupus erythematosus	4.67e-05	0.000147	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisone—systemic lupus erythematosus	4.66e-05	0.000147	CcSEcCtD
Aripiprazole—Pruritus—Triamcinolone—systemic lupus erythematosus	4.65e-05	0.000146	CcSEcCtD
Aripiprazole—Cough—Methotrexate—systemic lupus erythematosus	4.64e-05	0.000146	CcSEcCtD
Aripiprazole—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.64e-05	0.000146	CcSEcCtD
Aripiprazole—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.62e-05	0.000145	CcSEcCtD
Aripiprazole—Convulsion—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000145	CcSEcCtD
Aripiprazole—Dyspepsia—Prednisone—systemic lupus erythematosus	4.57e-05	0.000144	CcSEcCtD
Aripiprazole—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.55e-05	0.000143	CcSEcCtD
Aripiprazole—Arthralgia—Methotrexate—systemic lupus erythematosus	4.53e-05	0.000143	CcSEcCtD
Aripiprazole—Chest pain—Methotrexate—systemic lupus erythematosus	4.53e-05	0.000143	CcSEcCtD
Aripiprazole—Myalgia—Methotrexate—systemic lupus erythematosus	4.53e-05	0.000143	CcSEcCtD
Aripiprazole—Decreased appetite—Prednisone—systemic lupus erythematosus	4.52e-05	0.000142	CcSEcCtD
Aripiprazole—Rash—Prednisolone—systemic lupus erythematosus	4.51e-05	0.000142	CcSEcCtD
Aripiprazole—Dermatitis—Prednisolone—systemic lupus erythematosus	4.5e-05	0.000142	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	4.5e-05	0.000142	CcSEcCtD
Aripiprazole—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.49e-05	0.000141	CcSEcCtD
Aripiprazole—Fatigue—Prednisone—systemic lupus erythematosus	4.48e-05	0.000141	CcSEcCtD
Aripiprazole—Headache—Prednisolone—systemic lupus erythematosus	4.48e-05	0.000141	CcSEcCtD
Aripiprazole—Discomfort—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000141	CcSEcCtD
Aripiprazole—Constipation—Prednisone—systemic lupus erythematosus	4.44e-05	0.00014	CcSEcCtD
Aripiprazole—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.44e-05	0.00014	CcSEcCtD
Aripiprazole—Rash—Hydrocortisone—systemic lupus erythematosus	4.4e-05	0.000139	CcSEcCtD
Aripiprazole—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.4e-05	0.000138	CcSEcCtD
Aripiprazole—Confusional state—Methotrexate—systemic lupus erythematosus	4.38e-05	0.000138	CcSEcCtD
Aripiprazole—Headache—Hydrocortisone—systemic lupus erythematosus	4.37e-05	0.000138	CcSEcCtD
Aripiprazole—Dizziness—Triamcinolone—systemic lupus erythematosus	4.35e-05	0.000137	CcSEcCtD
Aripiprazole—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000137	CcSEcCtD
Aripiprazole—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.34e-05	0.000137	CcSEcCtD
Aripiprazole—Infection—Methotrexate—systemic lupus erythematosus	4.31e-05	0.000136	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.28e-05	0.000135	CcSEcCtD
Aripiprazole—Asthenia—Dexamethasone—systemic lupus erythematosus	4.28e-05	0.000135	CcSEcCtD
Aripiprazole—Asthenia—Betamethasone—systemic lupus erythematosus	4.28e-05	0.000135	CcSEcCtD
Aripiprazole—Nervous system disorder—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000134	CcSEcCtD
Aripiprazole—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.25e-05	0.000134	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.25e-05	0.000134	CcSEcCtD
Aripiprazole—Nausea—Prednisolone—systemic lupus erythematosus	4.25e-05	0.000134	CcSEcCtD
Aripiprazole—Pruritus—Dexamethasone—systemic lupus erythematosus	4.22e-05	0.000133	CcSEcCtD
Aripiprazole—Pruritus—Betamethasone—systemic lupus erythematosus	4.22e-05	0.000133	CcSEcCtD
Aripiprazole—Skin disorder—Methotrexate—systemic lupus erythematosus	4.22e-05	0.000133	CcSEcCtD
Aripiprazole—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	4.2e-05	0.000132	CcSEcCtD
Aripiprazole—Vomiting—Triamcinolone—systemic lupus erythematosus	4.18e-05	0.000132	CcSEcCtD
Aripiprazole—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.17e-05	0.000131	CcSEcCtD
Aripiprazole—Nausea—Hydrocortisone—systemic lupus erythematosus	4.15e-05	0.000131	CcSEcCtD
Aripiprazole—Rash—Triamcinolone—systemic lupus erythematosus	4.14e-05	0.000131	CcSEcCtD
Aripiprazole—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.14e-05	0.00013	CcSEcCtD
Aripiprazole—Anorexia—Methotrexate—systemic lupus erythematosus	4.14e-05	0.00013	CcSEcCtD
Aripiprazole—Rash—Methylprednisolone—systemic lupus erythematosus	4.14e-05	0.00013	CcSEcCtD
Aripiprazole—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.13e-05	0.00013	CcSEcCtD
Aripiprazole—Urticaria—Prednisone—systemic lupus erythematosus	4.13e-05	0.00013	CcSEcCtD
Aripiprazole—Headache—Triamcinolone—systemic lupus erythematosus	4.12e-05	0.00013	CcSEcCtD
Aripiprazole—Headache—Methylprednisolone—systemic lupus erythematosus	4.11e-05	0.000129	CcSEcCtD
Aripiprazole—Body temperature increased—Prednisone—systemic lupus erythematosus	4.11e-05	0.000129	CcSEcCtD
Aripiprazole—Abdominal pain—Prednisone—systemic lupus erythematosus	4.11e-05	0.000129	CcSEcCtD
Aripiprazole—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.08e-05	0.000129	CcSEcCtD
Aripiprazole—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.08e-05	0.000129	CcSEcCtD
Aripiprazole—Hypotension—Methotrexate—systemic lupus erythematosus	4.06e-05	0.000128	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.96e-05	0.000125	CcSEcCtD
Aripiprazole—Dizziness—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.000124	CcSEcCtD
Aripiprazole—Dizziness—Betamethasone—systemic lupus erythematosus	3.94e-05	0.000124	CcSEcCtD
Aripiprazole—Insomnia—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000124	CcSEcCtD
Aripiprazole—Nausea—Triamcinolone—systemic lupus erythematosus	3.9e-05	0.000123	CcSEcCtD
Aripiprazole—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.9e-05	0.000123	CcSEcCtD
Aripiprazole—Nausea—Methylprednisolone—systemic lupus erythematosus	3.9e-05	0.000123	CcSEcCtD
Aripiprazole—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.87e-05	0.000122	CcSEcCtD
Aripiprazole—Somnolence—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000122	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.83e-05	0.000121	CcSEcCtD
Aripiprazole—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.82e-05	0.00012	CcSEcCtD
Aripiprazole—Vomiting—Dexamethasone—systemic lupus erythematosus	3.79e-05	0.000119	CcSEcCtD
Aripiprazole—Vomiting—Betamethasone—systemic lupus erythematosus	3.79e-05	0.000119	CcSEcCtD
Aripiprazole—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.77e-05	0.000119	CcSEcCtD
Aripiprazole—Rash—Dexamethasone—systemic lupus erythematosus	3.76e-05	0.000118	CcSEcCtD
Aripiprazole—Rash—Betamethasone—systemic lupus erythematosus	3.76e-05	0.000118	CcSEcCtD
Aripiprazole—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.76e-05	0.000118	CcSEcCtD
Aripiprazole—Dermatitis—Betamethasone—systemic lupus erythematosus	3.76e-05	0.000118	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000118	CcSEcCtD
Aripiprazole—Fatigue—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000118	CcSEcCtD
Aripiprazole—Headache—Dexamethasone—systemic lupus erythematosus	3.74e-05	0.000118	CcSEcCtD
Aripiprazole—Headache—Betamethasone—systemic lupus erythematosus	3.74e-05	0.000118	CcSEcCtD
Aripiprazole—Asthenia—Prednisone—systemic lupus erythematosus	3.73e-05	0.000117	CcSEcCtD
Aripiprazole—Pain—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000117	CcSEcCtD
Aripiprazole—Pruritus—Prednisone—systemic lupus erythematosus	3.68e-05	0.000116	CcSEcCtD
Aripiprazole—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.58e-05	0.000113	CcSEcCtD
Aripiprazole—Diarrhoea—Prednisone—systemic lupus erythematosus	3.55e-05	0.000112	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.55e-05	0.000112	CcSEcCtD
Aripiprazole—Nausea—Betamethasone—systemic lupus erythematosus	3.54e-05	0.000112	CcSEcCtD
Aripiprazole—Nausea—Dexamethasone—systemic lupus erythematosus	3.54e-05	0.000112	CcSEcCtD
Aripiprazole—Urticaria—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000109	CcSEcCtD
Aripiprazole—Dizziness—Prednisone—systemic lupus erythematosus	3.44e-05	0.000108	CcSEcCtD
Aripiprazole—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.43e-05	0.000108	CcSEcCtD
Aripiprazole—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.43e-05	0.000108	CcSEcCtD
Aripiprazole—Vomiting—Prednisone—systemic lupus erythematosus	3.3e-05	0.000104	CcSEcCtD
Aripiprazole—Rash—Prednisone—systemic lupus erythematosus	3.28e-05	0.000103	CcSEcCtD
Aripiprazole—Dermatitis—Prednisone—systemic lupus erythematosus	3.27e-05	0.000103	CcSEcCtD
Aripiprazole—Headache—Prednisone—systemic lupus erythematosus	3.25e-05	0.000102	CcSEcCtD
Aripiprazole—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000101	CcSEcCtD
Aripiprazole—Asthenia—Methotrexate—systemic lupus erythematosus	3.11e-05	9.81e-05	CcSEcCtD
Aripiprazole—Nausea—Prednisone—systemic lupus erythematosus	3.09e-05	9.72e-05	CcSEcCtD
Aripiprazole—Pruritus—Methotrexate—systemic lupus erythematosus	3.07e-05	9.67e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.97e-05	9.35e-05	CcSEcCtD
Aripiprazole—Dizziness—Methotrexate—systemic lupus erythematosus	2.87e-05	9.04e-05	CcSEcCtD
Aripiprazole—Vomiting—Methotrexate—systemic lupus erythematosus	2.76e-05	8.69e-05	CcSEcCtD
Aripiprazole—Rash—Methotrexate—systemic lupus erythematosus	2.74e-05	8.62e-05	CcSEcCtD
Aripiprazole—Dermatitis—Methotrexate—systemic lupus erythematosus	2.73e-05	8.61e-05	CcSEcCtD
Aripiprazole—Headache—Methotrexate—systemic lupus erythematosus	2.72e-05	8.56e-05	CcSEcCtD
Aripiprazole—Nausea—Methotrexate—systemic lupus erythematosus	2.58e-05	8.12e-05	CcSEcCtD
Aripiprazole—HTR6—Signaling Pathways—EP300—systemic lupus erythematosus	5.03e-06	7.77e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—EP300—systemic lupus erythematosus	5.03e-06	7.76e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—NOS3—systemic lupus erythematosus	5.02e-06	7.75e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	5.02e-06	7.74e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MMP9—systemic lupus erythematosus	5.01e-06	7.73e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	5e-06	7.72e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—EP300—systemic lupus erythematosus	5e-06	7.71e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.99e-06	7.7e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.99e-06	7.7e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	4.97e-06	7.66e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.94e-06	7.62e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	4.91e-06	7.57e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.9e-06	7.56e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—EP300—systemic lupus erythematosus	4.89e-06	7.55e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	4.87e-06	7.52e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.87e-06	7.52e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MMP9—systemic lupus erythematosus	4.85e-06	7.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	4.85e-06	7.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	4.83e-06	7.45e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL2—systemic lupus erythematosus	4.83e-06	7.45e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.83e-06	7.45e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—systemic lupus erythematosus	4.83e-06	7.45e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	4.83e-06	7.45e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	4.81e-06	7.43e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—EP300—systemic lupus erythematosus	4.81e-06	7.43e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.81e-06	7.42e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MMP9—systemic lupus erythematosus	4.8e-06	7.4e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.78e-06	7.38e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.77e-06	7.36e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	4.77e-06	7.36e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.76e-06	7.35e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	4.75e-06	7.34e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—EP300—systemic lupus erythematosus	4.75e-06	7.33e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.75e-06	7.33e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	4.74e-06	7.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	4.74e-06	7.32e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.74e-06	7.31e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.73e-06	7.3e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	4.72e-06	7.29e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCL2—systemic lupus erythematosus	4.71e-06	7.27e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	4.67e-06	7.2e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	4.66e-06	7.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.65e-06	7.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	4.65e-06	7.17e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.63e-06	7.15e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	4.61e-06	7.11e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—EP300—systemic lupus erythematosus	4.6e-06	7.09e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PTGS2—systemic lupus erythematosus	4.59e-06	7.08e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.57e-06	7.06e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.56e-06	7.04e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.55e-06	7.03e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—EP300—systemic lupus erythematosus	4.55e-06	7.02e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	4.51e-06	6.96e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.5e-06	6.94e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.49e-06	6.94e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	4.44e-06	6.85e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.44e-06	6.85e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	4.41e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.4e-06	6.79e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.38e-06	6.76e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.38e-06	6.75e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.37e-06	6.75e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.35e-06	6.72e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.34e-06	6.7e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	4.34e-06	6.7e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EP300—systemic lupus erythematosus	4.33e-06	6.69e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.32e-06	6.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.32e-06	6.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	4.31e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.31e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.31e-06	6.65e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.3e-06	6.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	4.3e-06	6.64e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.3e-06	6.64e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.29e-06	6.62e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	4.28e-06	6.61e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	4.28e-06	6.6e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TYK2—systemic lupus erythematosus	4.28e-06	6.6e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—systemic lupus erythematosus	4.27e-06	6.59e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.25e-06	6.56e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.24e-06	6.55e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.23e-06	6.53e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.23e-06	6.53e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.22e-06	6.52e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.22e-06	6.52e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.22e-06	6.52e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	4.22e-06	6.51e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	4.21e-06	6.5e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.21e-06	6.5e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NOS3—systemic lupus erythematosus	4.2e-06	6.48e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.18e-06	6.46e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.16e-06	6.41e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	4.15e-06	6.41e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.14e-06	6.4e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.13e-06	6.38e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	4.13e-06	6.38e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.13e-06	6.37e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	4.11e-06	6.35e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.11e-06	6.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.11e-06	6.34e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.1e-06	6.34e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.09e-06	6.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	4.07e-06	6.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.06e-06	6.26e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.05e-06	6.25e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.04e-06	6.24e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	4.02e-06	6.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	4e-06	6.17e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.99e-06	6.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	3.96e-06	6.1e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.95e-06	6.1e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	3.94e-06	6.07e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.93e-06	6.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.92e-06	6.05e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.92e-06	6.05e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	3.91e-06	6.04e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.9e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	3.9e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	3.86e-06	5.96e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	3.86e-06	5.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.85e-06	5.94e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—EP300—systemic lupus erythematosus	3.82e-06	5.89e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	3.8e-06	5.87e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.79e-06	5.85e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.77e-06	5.81e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	3.74e-06	5.78e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.73e-06	5.76e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	3.73e-06	5.75e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.73e-06	5.75e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.72e-06	5.74e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	3.71e-06	5.72e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.7e-06	5.71e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.69e-06	5.7e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.67e-06	5.66e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.66e-06	5.65e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.66e-06	5.64e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.65e-06	5.63e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	3.65e-06	5.63e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.64e-06	5.61e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	3.63e-06	5.6e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3.61e-06	5.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	3.61e-06	5.57e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.6e-06	5.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.59e-06	5.54e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	3.59e-06	5.54e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	3.58e-06	5.53e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.57e-06	5.51e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—systemic lupus erythematosus	3.57e-06	5.51e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	3.56e-06	5.5e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—systemic lupus erythematosus	3.56e-06	5.49e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	3.55e-06	5.48e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	3.55e-06	5.48e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—systemic lupus erythematosus	3.54e-06	5.46e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.53e-06	5.45e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	3.52e-06	5.44e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	3.51e-06	5.42e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.51e-06	5.42e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	3.51e-06	5.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	3.5e-06	5.41e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.5e-06	5.4e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	3.49e-06	5.38e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.45e-06	5.33e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.44e-06	5.31e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.42e-06	5.27e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.4e-06	5.24e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.39e-06	5.23e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.39e-06	5.23e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.38e-06	5.22e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.38e-06	5.21e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.38e-06	5.21e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—systemic lupus erythematosus	3.37e-06	5.2e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.37e-06	5.19e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.36e-06	5.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.36e-06	5.18e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.35e-06	5.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.34e-06	5.15e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.33e-06	5.15e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.33e-06	5.14e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.33e-06	5.13e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.32e-06	5.13e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.31e-06	5.11e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—systemic lupus erythematosus	3.3e-06	5.09e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—systemic lupus erythematosus	3.29e-06	5.08e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—systemic lupus erythematosus	3.27e-06	5.05e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	3.27e-06	5.05e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	3.26e-06	5.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.25e-06	5.01e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.24e-06	5e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.22e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	3.22e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	3.21e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	3.21e-06	4.95e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—systemic lupus erythematosus	3.2e-06	4.95e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EP300—systemic lupus erythematosus	3.2e-06	4.94e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EP300—systemic lupus erythematosus	3.19e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.18e-06	4.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	3.16e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—systemic lupus erythematosus	3.15e-06	4.87e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	3.15e-06	4.87e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	3.14e-06	4.84e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.13e-06	4.84e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—systemic lupus erythematosus	3.11e-06	4.8e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.1e-06	4.78e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.09e-06	4.77e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.09e-06	4.76e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.08e-06	4.75e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.05e-06	4.71e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.04e-06	4.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.03e-06	4.68e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.02e-06	4.67e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—systemic lupus erythematosus	3.01e-06	4.65e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	3e-06	4.63e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.99e-06	4.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.99e-06	4.61e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—systemic lupus erythematosus	2.98e-06	4.6e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	2.93e-06	4.52e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.91e-06	4.5e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.84e-06	4.39e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—systemic lupus erythematosus	2.84e-06	4.38e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	2.8e-06	4.32e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.8e-06	4.32e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.79e-06	4.31e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.78e-06	4.3e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.77e-06	4.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.77e-06	4.28e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.75e-06	4.24e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	2.74e-06	4.24e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.74e-06	4.23e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	2.55e-06	3.94e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.55e-06	3.93e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	2.53e-06	3.9e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	2.44e-06	3.77e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.43e-06	3.75e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.42e-06	3.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.36e-06	3.65e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	2.32e-06	3.59e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.28e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.28e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	2.14e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.11e-06	3.26e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	2.1e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—systemic lupus erythematosus	2.1e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—systemic lupus erythematosus	2.09e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	2.07e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	2.07e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.05e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.96e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.92e-06	2.96e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.79e-06	2.77e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.49e-06	2.3e-05	CbGpPWpGaD
